Dec 15, 2023

January 26, 2025

This week’s newsletter included:

• Governor Cox Announces the Launch of the Utah Innovation Fund
• BioUtah Podcast Series: “Life Sciences in Action” with Meredith Krannich and Deno Himonas of Wilson Sonsini
• Halia Therapeutics Co-Founder David J. Bearss Featured in Utah Business
• Halia Therapeutics Dosed Its First Patient in Phase 2a Clinical Trial of HT-6184, a First-in-Class NLRP3-Inhibitor, for the Treatment of Lower-Risk Myelodysplastic Syndromes
• Central Texas Angel Network Makes Significant Investment in Phoenix PharmaLabs
• Inherent Biosciences Receives Investment from Utah Innovation Fund
• BD Receives FDA 510(k) Clearance for Potentially Transformative Fingertip Blood Collection Device
• Two University of Utah Innovators Selected as National Academy of Inventors Fellows
• BioHive Wraps Up Food Drive
• Metrodora Hosts Governor Cox
• Technology Licensing Office at the University of Utah Announces New Processes for Tech Transfer
• 100 Companies Championing Women